Uptake of long-acting reversible contraception after telemedicine delivered abortion during Covid-19.

IF 1.5 3区 生物学 Q4 EVOLUTIONARY BIOLOGY
Australian Systematic Botany Pub Date : 2022-08-01 Epub Date: 2022-06-17 DOI:10.1080/13625187.2022.2085680
Angharad Dixon, John J Reynolds-Wright, Sharon T Cameron
{"title":"Uptake of long-acting reversible contraception after telemedicine delivered abortion during Covid-19.","authors":"Angharad Dixon, John J Reynolds-Wright, Sharon T Cameron","doi":"10.1080/13625187.2022.2085680","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>During COVID-19, early medical abortion (EMA) at home in Scotland was largely delivered by telemedicine. Short-acting post-abortion contraception was provided with EMA medications, but long-acting reversible contraception (LARC) (implant, injectable and intrauterine device) required an in-person visit. We wished to assess LARC uptake following telemedicine abortion, and factors associated with method receipt.</p><p><strong>Methods: </strong>A prospective observational cohort study of patients accessing abortion via NHS Lothian (October 2020 to February 2021). Patients were offered contraception at telemedicine consultation and their choice was recorded in their clinical notes. Those wishing LARC were directed to the service's rapid-access LARC clinic. We reviewed electronic patient records six weeks post-abortion to determine whether patients received their chosen method.</p><p><strong>Results: </strong>944 patients had an abortion; 768 (81.4%) had EMA, 131 (13.9%) had a medical or surgical abortion in hospital. The most popular contraceptive method was the progestogen-only pill (<i>n</i> = 324, 34%). 330 patients (35%) requested LARC but less than half (153/330; 46%) received this. Of patients choosing LARC, those who attended the clinic for a pre-abortion ultrasound, or had an abortion in hospital, were more likely to initiate LARC than those having full telemedicine EMA. Nulliparity, gestation over 7 weeks, and age under-26 years were also positively associated with initiating LARC.</p><p><strong>Conclusion: </strong>During COVID-19 there was demand for post-abortion LARC but less than half of patients received this by six weeks. Provision was enhanced when in-person clinical interactions took place. Interventions are required to facilitate timely access and initiation of LARC with telemedicine delivered abortion care.</p>","PeriodicalId":55416,"journal":{"name":"Australian Systematic Botany","volume":"19 1","pages":"284-288"},"PeriodicalIF":1.5000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian Systematic Botany","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/13625187.2022.2085680","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/17 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"EVOLUTIONARY BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: During COVID-19, early medical abortion (EMA) at home in Scotland was largely delivered by telemedicine. Short-acting post-abortion contraception was provided with EMA medications, but long-acting reversible contraception (LARC) (implant, injectable and intrauterine device) required an in-person visit. We wished to assess LARC uptake following telemedicine abortion, and factors associated with method receipt.

Methods: A prospective observational cohort study of patients accessing abortion via NHS Lothian (October 2020 to February 2021). Patients were offered contraception at telemedicine consultation and their choice was recorded in their clinical notes. Those wishing LARC were directed to the service's rapid-access LARC clinic. We reviewed electronic patient records six weeks post-abortion to determine whether patients received their chosen method.

Results: 944 patients had an abortion; 768 (81.4%) had EMA, 131 (13.9%) had a medical or surgical abortion in hospital. The most popular contraceptive method was the progestogen-only pill (n = 324, 34%). 330 patients (35%) requested LARC but less than half (153/330; 46%) received this. Of patients choosing LARC, those who attended the clinic for a pre-abortion ultrasound, or had an abortion in hospital, were more likely to initiate LARC than those having full telemedicine EMA. Nulliparity, gestation over 7 weeks, and age under-26 years were also positively associated with initiating LARC.

Conclusion: During COVID-19 there was demand for post-abortion LARC but less than half of patients received this by six weeks. Provision was enhanced when in-person clinical interactions took place. Interventions are required to facilitate timely access and initiation of LARC with telemedicine delivered abortion care.

在 Covid-19 期间通过远程医疗进行人工流产后长效可逆避孕药具的使用情况。
背景:在 COVID-19 期间,苏格兰的家庭早期药物流产 (EMA) 主要通过远程医疗提供。流产后短效避孕药物随 EMA 药物一起提供,但长效可逆避孕药物 (LARC)(植入、注射和宫内节育器)则需要亲自到医院就诊。我们希望评估远程医疗流产后的 LARC 使用情况,以及与接受避孕方法相关的因素:一项前瞻性观察性队列研究,对象是通过诺丁汉国家医疗服务系统(NHS Lothian)进行人工流产的患者(2020 年 10 月至 2021 年 2 月)。患者在接受远程医疗咨询时可获得避孕药具,他们的选择将记录在临床笔记中。希望接受 LARC 的患者将被引导至该服务的快速 LARC 诊所。我们查看了流产后六周的电子病历,以确定患者是否接受了所选方法:944名患者进行了人工流产,其中768人(81.4%)使用了EMA,131人(13.9%)在医院进行了药物或手术流产。最常用的避孕方法是纯孕激素避孕药(324 人,34%)。330 名患者(35%)要求使用 LARC,但只有不到一半的患者(153/330;46%)接受了这种方法。在选择 LARC 的患者中,到诊所进行流产前超声波检查或在医院进行流产的患者比接受过全程远程医疗 EMA 的患者更有可能开始使用 LARC。无子宫、妊娠超过 7 周和年龄在 26 岁以下也与开始 LARC 呈正相关:结论:在 COVID-19 期间,患者对流产后 LARC 有需求,但只有不到一半的患者在六周前接受了 LARC。在进行面对面的临床互动时,提供情况会有所改善。需要采取干预措施,通过远程医疗提供的人工流产护理来促进 LARC 的及时获取和启动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Australian Systematic Botany
Australian Systematic Botany 生物-进化生物学
CiteScore
3.10
自引率
12.50%
发文量
12
审稿时长
>12 weeks
期刊介绍: Australian Systematic Botany is an international journal devoted to the systematics, taxonomy, and related aspects of biogeography and evolution of all algae, fungi and plants, including fossils. Descriptive taxonomic papers should normally constitute a comprehensive treatment of a group. Short papers on individual species and nomenclatural papers must contain significant new information of broader interest to be considered. The prestigious L.A.S. Johnson Review Series is published. Other review articles will also be considered. All papers are peer reviewed. Australian Systematic Botany is published with the endorsement of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the Australian Academy of Science.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信